The conversation around the legalization of cannabis has changed significantly over the past decade, moving from the fringes of public policy debates to the forefront of legislative action in many parts of the world. Central to this dialogue is the potential impact of legalization on the innovation of pharmaceutical THC (tetrahydrocannabinol) and CBD (cannabidiol) medicines.  […]